103 related articles for article (PubMed ID: 26998533)
1. An enzyme-responsive controlled release system based on a dual-functional peptide.
Li X; Burger S; O'Connor AJ; Ong L; Karas JA; Gras SL
Chem Commun (Camb); 2016 Apr; 52(29):5112-5. PubMed ID: 26998533
[TBL] [Abstract][Full Text] [Related]
2. Stimuli-responsive conformational conversion of peptide gatekeepers for controlled release of guests from mesoporous silica nanocontainers.
Lee J; Kim H; Han S; Hong E; Lee KH; Kim C
J Am Chem Soc; 2014 Sep; 136(37):12880-3. PubMed ID: 25188823
[TBL] [Abstract][Full Text] [Related]
3. Triggered release in lipid bilayer-capped mesoporous silica nanoparticles containing SPION using an alternating magnetic field.
Bringas E; Köysüren Ö; Quach DV; Mahmoudi M; Aznar E; Roehling JD; Marcos MD; Martínez-Máñez R; Stroeve P
Chem Commun (Camb); 2012 Jun; 48(45):5647-9. PubMed ID: 22543447
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-responsive intracellular-controlled release using silica mesoporous nanoparticles capped with ε-poly-L-lysine.
Mondragón L; Mas N; Ferragud V; de la Torre C; Agostini A; Martínez-Máñez R; Sancenón F; Amorós P; Pérez-Payá E; Orzáez M
Chemistry; 2014 Apr; 20(18):5271-81. PubMed ID: 24700694
[TBL] [Abstract][Full Text] [Related]
5. Peptide modified mesoporous silica nanocontainers.
Porta F; Lamers GE; Zink JI; Kros A
Phys Chem Chem Phys; 2011 Jun; 13(21):9982-5. PubMed ID: 21739680
[TBL] [Abstract][Full Text] [Related]
6. Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug.
Popovici RF; Seftel EM; Mihai GD; Popovici E; Voicu VA
J Pharm Sci; 2011 Feb; 100(2):704-14. PubMed ID: 20740675
[TBL] [Abstract][Full Text] [Related]
7. Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance.
Han N; Zhao Q; Wan L; Wang Y; Gao Y; Wang P; Wang Z; Zhang J; Jiang T; Wang S
ACS Appl Mater Interfaces; 2015 Feb; 7(5):3342-51. PubMed ID: 25584634
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
Giri S; Trewyn BG; Lin VS
Nanomedicine (Lond); 2007 Feb; 2(1):99-111. PubMed ID: 17716196
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive release of acetal-linked melittin from SBA-15 mesoporous silica.
Schlossbauer A; Dohmen C; Schaffert D; Wagner E; Bein T
Angew Chem Int Ed Engl; 2011 Jul; 50(30):6828-30. PubMed ID: 21688354
[No Abstract] [Full Text] [Related]
11. DNA-based intelligent logic controlled release systems.
Wen Y; Xu L; Li C; Du H; Chen L; Su B; Zhang Z; Zhang X; Song Y
Chem Commun (Camb); 2012 Aug; 48(67):8410-2. PubMed ID: 22801748
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
[TBL] [Abstract][Full Text] [Related]
13. Enzyme and voltage stimuli-responsive controlled release system based on β-cyclodextrin-capped mesoporous silica nanoparticles.
Xiao Y; Wang T; Cao Y; Wang X; Zhang Y; Liu Y; Huo Q
Dalton Trans; 2015 Mar; 44(9):4355-61. PubMed ID: 25639347
[TBL] [Abstract][Full Text] [Related]
14. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles.
Giri S; Trewyn BG; Stellmaker MP; Lin VS
Angew Chem Int Ed Engl; 2005 Aug; 44(32):5038-44. PubMed ID: 16038000
[No Abstract] [Full Text] [Related]
15. Control-release microcapsule of famotidine loaded biomimetic synthesized mesoporous silica nanoparticles: Controlled release effect and enhanced stomach adhesion in vitro.
Li J; Wang H; Yang B; Xu L; Zheng N; Chen H; Li S
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():273-7. PubMed ID: 26478311
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of chlorhexidine from amorphous microporous silica.
Verraedt E; Pendela M; Adams E; Hoogmartens J; Martens JA
J Control Release; 2010 Feb; 142(1):47-52. PubMed ID: 19804804
[TBL] [Abstract][Full Text] [Related]
17. A facile route for rapid synthesis of hollow mesoporous silica nanoparticles as pH-responsive delivery carrier.
Xu H; Zhang H; Wang D; Wu L; Liu X; Jiao Z
J Colloid Interface Sci; 2015 Aug; 451():101-7. PubMed ID: 25890118
[TBL] [Abstract][Full Text] [Related]
18. Drug encapsulation and release by mesoporous silica nanoparticles: the effect of surface functional groups.
Tan SY; Ang CY; Li P; Yap QM; Zhao Y
Chemistry; 2014 Sep; 20(36):11276-82. PubMed ID: 25044108
[TBL] [Abstract][Full Text] [Related]
19. Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles.
Song B; Wu C; Chang J
Acta Biomater; 2012 May; 8(5):1901-7. PubMed ID: 22326789
[TBL] [Abstract][Full Text] [Related]
20. Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure.
Zhu Y; Shi J; Shen W; Dong X; Feng J; Ruan M; Li Y
Angew Chem Int Ed Engl; 2005 Aug; 44(32):5083-7. PubMed ID: 16015668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
